135 Advisory to all manufacturer of cough syrup, various critical excipients 2023-Dec-05 418 KB
F. No. 42-107/2023-DC(Pt-MISC-SND) Central Drugs Standard Control Organisation Ministry of Health and Family Welfare Govt. of India (SND DIVISION) Date: 5'”
Date: 5'” December, 2023
ADVISORY
Under the Drugs and Cosmetics Act and Rules there under the drug manufacturers are required to manufacture the drugs adhering strictly to the conditions of manufacturing license and prescribed Good Manufacturing Practices to ensure that the drugs manufactured for marketing are of quality standards and meets the parameters of quality, safety and efficacy. ; In order to ensure quality, safety and efficacy of drugs formulation it is of paramount importance that such formulation are manufactured in compliance with the prescribed standards not only in respect of API but also various excipients used for manufacturing of the formulations. Therefore, the quality, safety and efficacy of both APlIs and the excipients are crucial.
In case of manufacture of cough syrups, various critical excipients like propylene glycol, glycerine, sorbitol etc. are used. The manufacturers are required to ensure that these excipients meet the regulatory standards of quality so as to avoid any contamination in the formulations manufactured by using such excipients During winter seasons, there may be increase in use of cough syrups in the country. In view of above, the manufacturers are hereby advised that they should purchase and use only pharma grade excipients from their approved sources/vendors which are of quality standards in accordance with the regulatory requirements under the provisions of the said Act & Rules to ensure quality, safety— and efficacy of the drug formulations. Dr. Raje Singh ian Drugs Co ller General (india)
To All Stakeholders & CDSCO Website
-
Copy to: 1) All State / UT Drugs Controllers to direct all the manufacturers under their jurisdiction to use only pharma grade excipients in manufacturing of drug formulations
-
- All Zonal & Sub Zonal offices of CDSCO for follow up with the concerned State
Copy for information to: 1) PPS to AS (Regulation), MoHF&W, Nirman Bhawan, New Delhi
Verbatim extracted text (OCR/PDF). Older scans and tables may show extraction artifacts — verify against the original for anything you act on.
No analysis has been generated for this document yet.